Xu, Li

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study

Qin, S., Chan, S. L., Gu, S., Bai, Y., Ren, Z., Lin, X., Chen, Z., Jia, W., Jin, Y., Guo, Y., et al. (2023) · The Lancet

Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers

Cited by 746

Impact of supervised beego, a traditional Chinese water-only fasting, on thrombosis and haemostasis

Fang, Y., Gu, Y., Zhao, C., Lv, Y., Qian, J., Zhu, L., Yuan, N., Zhang, S., Wang, L., Li, M., et al. (2021) · BMJ Nutrition, Prevention & Health

Dietary Effects on HealthPlatelet Disorders and Treatments

Cited by 19

Supervised beego, a traditional Chinese water-only fasting, ends up with reduced thrombosis risk without compromising hemostasis capacity

Fang, Y., Gu, Y., Zhao, C., Lv, Y., Qian, J., Zhu, L., Yuan, N., Zhang, S., Wang, L., Li, M., et al. (2020) · BMJ Nutrition Prevention & Health

Dietary Effects on HealthPlatelet Disorders and Treatments

Cited by 19